🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate the efficacy of a booster...
Status
Enrolling By Invitation
Location
Cantonal Hospital Aarau
Start Date
2023-11-13
Trial ID
NCT06037564
Treatments Being Tested
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
The goal of this clinical study is to provide continued access to the study...
Status
Recruiting
Location
Helios Salud
Start Date
2024-08-27
Trial ID
NCT06337032
Treatments Being Tested
Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ...
Status
Completed
Location
Yarosslavl Clinical Hospital #3
Start Date
2019-06-06
Trial ID
NCT04268472
This is a pilot, proof of concept, open-label clinical trial, to assess the...
Status
Completed
Location
Germans Trias i Pujol Hospital
Start Date
2012-05
Trial ID
NCT01480713
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of switchin...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-08-28
Trial ID
NCT03631732
Treatments Being Tested
Study to determine the effect of steady-state plasma concentration of Tipra...
Status
Completed
Location
Multiple Locations
Start Date
2007-08
Trial ID
NCT02251795
Treatments Being Tested
The purpose of this randomized, open-label, multicenter, active-controlled ...
Status
Completed
Location
University of Alabama - Birmingham
Start Date
2010-11
Trial ID
NCT01252940
Treatments Being Tested
This study will evaluate the efficacy of switching from emtricitabine/tenof...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-05-06
Trial ID
NCT02121795
Treatments Being Tested
The objective of this study is to compare the efficacy and safety of Tipran...
Status
Terminated
Location
1182.71.1109 Boehringer Ingelheim Investigational Site
Start Date
2007-09
Trial ID
NCT00517192
Treatments Being Tested